1.
|
Details of the person discharging managerial responsibilities / person closely associated
| ||
(a)
|
Name
|
Aradhana Sarin
| |
2.
|
Reason for the notification
| ||
(a)
|
Position/status
|
Chief Financial Officer
| |
(b)
|
Initial notification/ Amendment
|
Initial notification
| |
3.
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||
(a)
|
Name
|
AstraZeneca PLC
| |
(b)
|
LEI
|
PY6ZZQWO2IZFZC3IOL08
| |
4.
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| ||
(a)
|
Description of the financial instrument, type of instrument
|
Ordinary Shares of US$0.25 each in AstraZeneca PLC
| |
(b)
|
Identification code
|
GB0009895292
| |
(c)
|
Nature of the transaction
|
Grants of compensatory restricted share award and ordinary course award under the AstraZeneca Performance Share Plan
| |
(d)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
|
£82.09
|
31,690
| ||
(e)
|
Aggregated information
- Aggregated volume
- Price
|
Not applicable
| |
(f)
|
Date of the transaction
|
13 August 2021
| |
(g)
|
Place of the transaction
|
Outside a trading venue
|
Attachments
- Original document
- Permalink
Disclaimer
AstraZeneca plc published this content on 16 August 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 16 August 2021 14:52:07 UTC.